Keli Lima

12PUBLICATIONS
34CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 25, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies.

|Sep 22, 2025
New molecular targets in acute leukemias: cytoskeletal regulatory proteins.

João Agostinho Machado-Neto, Hugo Passos Vicari, Jean Carlos Lipreri da Silva

|Apr 05, 2025
Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitors.

Jorge Antonio Elias Godoy Carlos, Mauricio Temotheo Tavares, Keli Lima

|Dec 19, 2024
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes.

João Agostinho Machado-Neto, Hugo Passos Vicari, Jean Carlos Lipreri da Silva

|Dec 09, 2023
Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.

Keli Lima, Maria Fernanda Lopes Carvalho, Diego Antonio Pereira-Martins

|Aug 12, 2023
The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells.

Keli Lima, Lívia Bassani Lins de Miranda, Anali Del Milagro Bernabe Garnique

Pageof 2

Frequent Collaborators

12 joint publications

João Agostinho Machado-Neto

3 joint publications

Maria Fernanda Lopes Carvalho

3 joint publications

Hugo Passos Vicari

2 joint publications

Leticia Veras Costa-Lotufo